Catalio Capital Management, LP
SEC insider (Form 3/4/5 filer). CIK 0001958125. 10% Owner at Iambic Therapeutics, Inc. (IAM). 3 reported Form 4/5 transactions since Sep 2024; latest on Oct 16, 2026. Located in NEW YORK, NY.
Companies Catalio Capital Management, LP has filed insider reports for
- Iambic Therapeutics, Inc. (IAM): 10% Owner
Catalio Capital Management, LP
CIK: 0001958125
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)3 (100.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
IAM
Iambic Therapeutics, Inc.
10% Owner